| 
收听数0听众数8最后登录2025-1-7QQUID9301阅读权限10帖子1191精华0在线时间380 小时注册时间2014-5-1
 
 
 科研币2 速递币25 娱乐币1820 文献值0 资源值0 贡献值0 
 | 
5速递币 
| | 题名 | First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study. |  | 链接 | http://annonc.oxfordjournals.org/content/26/9/1883.long | 
 | 
 |